JW (Cayman) Therapeutics Co. Ltd.’s (JNY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting JW (Cayman) Therapeutics Co. Ltd. is a Buy.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 20-Day exponential moving average is EUR 0.26, while JW (Cayman) Therapeutics Co. Ltd.’s (JNY) share price is EUR 0.27, making it a Buy.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 50-Day exponential moving average is EUR 0.25, while JW (Cayman) Therapeutics Co. Ltd.’s (JNY) share price is EUR 0.27, making it a Buy.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 10-Day exponential moving average is EUR 0.25, while JW (Cayman) Therapeutics Co. Ltd.’s (JNY) share price is EUR 0.27, making it a Buy.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 100-Day exponential moving average is EUR 0.24, while JW (Cayman) Therapeutics Co. Ltd.’s (JNY) share price is EUR 0.27, making it a Buy.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) stock price is EUR 0.27 and JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 50-day simple moving average is EUR 0.26, creating a Buy signal.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) stock price is EUR 0.27 and JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 100-day simple moving average is EUR 0.22, creating a Buy signal.
JW (Cayman) Therapeutics Co. Ltd.’s (JNY) stock price is EUR 0.27 and JW (Cayman) Therapeutics Co. Ltd.’s (JNY) 200-day simple moving average is EUR 0.22, creating a Buy signal.